Over 20 markers were selected within the following categories: melanocyte-specific, apoptosis, cell cycle, DNA repair/damage, senescence and oxidative stress
Cole TA, Zhao H, Collier TJ, Sandoval I, Sortwell CE, Steece-Collier K, Daley BF, Booms A, Lipton J, Welch M, Berman M, Jandreski L, Graham D, Weihofen A, Celano S, Schulz E, Cole-Strauss A, Luna E, Quach D, Mohan A, Bennett CF, Swayze EE, Kordasiewicz HB, Luk KC, Paumier KL (2021) -Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinsons disease
Additionally, both BPC-157 and TB-500 are strictly prohibited by the World Anti-Doping Agency (WADA) and USADA
Mitochondrial etiology of neuropsychiatric disorders
& Baumgartner, M
Follow-Up: Regular follow-up appointments to monitor your progress and adjust your treatment as necessary.